ImmunityBio Securities Class Action Lawsuit
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
ImmunityBio · Anktiva · Ongoing Litigation
Last updated
Case overview
- Defendant company
- ImmunityBio
- Product or service
- Anktiva
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Availability is based on each listed participation option and its deadline.
Lead Plaintiff Application
Shareholders who purchased ImmunityBio shares during the class period from January 19, 2026, through March 24, 2026, could seek appointment as lead plaintiff.
Contact The Gross Law Firm regarding possible lead plaintiff appointment. The article states that appointment as lead plaintiff is not required to participate in any recovery.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.